Related Experiment Video
Updated: Mar 23, 2026
08:11
Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
3.7K
A dual potassium channel activator improves repolarization reserve and normalizes ventricular action potentials
Kirstine Calloe1, José M Di Diego2, Rie Schultz Hansen3
1Danish National Research Foundation Center for Cardiac Arrhythmias, Department of Veterinary Clinical and Animal Science, University of Copenhagen, DK-1870 Frederiksberg C, Denmark.
Biochemical Pharmacology
|March 23, 2016
Summary
A novel dual potassium current activator, NS3623, normalizes reduced repolarization reserve in cultured cardiac cells. This compound restores action potential configuration and suppresses early afterdepolarizations, suggesting therapeutic potential for heart failure.
Area of Science:
- Cardiovascular Physiology
- Electrophysiology
- Pharmacology
Background:
- Downregulation of potassium (K+) currents reduces repolarization reserve in ventricular myocytes.
- This reduction is observed in cultured cells and pathophysiological conditions like heart failure.
Purpose of the Study:
- To investigate K+ current downregulation in cultured canine cardiac myocytes.
- To determine if a dual K+ current activator, NS3623, can normalize these currents and restore action potential (AP) configuration.
Main Methods:
- Isolated canine ventricular myocytes were cultured for up to 48 hours.
- Patch clamp recordings measured Ito (transient outward K+ current) and IKr (rapid delayed rectifier K+ current).
- Action potentials were recorded, and the effect of NS3623 on AP configuration and afterdepolarizations was assessed.
Main Results:
- Culturing led to significant decreases in Ito and IKr density.
- NS3623 treatment increased both Ito and IKr magnitudes in cultured cells.
- NS3623 restored the AP notch, shortened AP duration, and suppressed early afterdepolarizations (EADs).
Conclusions:
- NS3623 acts as a dual activator of Ito and IKr.
- It effectively increases K+ currents, shortens AP duration, and suppresses EADs in cells with reduced repolarization reserve.
- K+ current activators like NS3623 may offer a therapeutic benefit in conditions characterized by reduced repolarization reserve, such as heart failure.
Related Concept Videos
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
2.9K
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
2.9K
01:20Antiepileptic Drugs: Potassium Channel Activators
916
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
916
01:30Cardiac Action Potential
8.4K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
8.4K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
4.0K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
4.0K
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
2.6K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
2.6K
01:28Depolarizing Blockers: Mechanism of Action
3.4K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
3.4K